David J Back Selected Research

David J Back Research Topics

Disease

6	Infections 10/2019 - 06/2005
5	COVID-19 12/2022 - 01/2020
5	HIV Infections (HIV Infection) 01/2021 - 03/2002
5	Tuberculosis (Tuberculoses) 12/2013 - 10/2002
5	Lipodystrophy 08/2013 - 10/2003
4	Insulin Resistance 01/2018 - 10/2003
3	Coinfection 10/2019 - 06/2008
3	Breast Neoplasms (Breast Cancer) 11/2009 - 12/2005
2	Hepatitis C 10/2019 - 07/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 08/2013
2	Malaria 01/2017 - 03/2013
2	Hypersensitivity (Allergy) 04/2014 - 10/2006
2	Body Weight (Weight, Body) 06/2011 - 06/2008
1	Chronic Disease (Chronic Diseases) 01/2021
1	Hemorrhage 10/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Dyslipidemias (Dyslipidemia) 07/2008
1	Fibrosis (Cirrhosis) 06/2008
1	Liver Diseases (Liver Disease) 06/2008
1	Necrosis 01/2005
1	Confusion (Bewilderment) 09/2003
1	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2002
1	Pleural Effusion (Pleural Effusions) 11/2002
1	Opportunistic Infections (Opportunistic Infection) 10/2002
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2002

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 12/2022 - 10/2002
4	Reverse Transcriptase InhibitorsIBA 04/2014 - 10/2003
4	Lopinavir FDA Link 01/2010 - 04/2002
4	Proteins (Proteins, Gene)FDA Link 11/2009 - 06/2005
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2009 - 12/2005
3	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2022 - 10/2002
3	NucleosidesIBA 04/2014 - 10/2003
3	Rifampin (Rifampicin)FDA LinkGeneric 03/2013 - 10/2002
3	Nevirapine (Viramune)FDA Link 01/2012 - 10/2006
3	Multidrug Resistance-Associated ProteinsIBA 11/2009 - 12/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 07/2008 - 04/2002
3	Blood Proteins (Serum Proteins)IBA 06/2008 - 09/2003
2	Antiviral Agents (Antivirals)IBA 12/2022 - 10/2019
2	SofosbuvirIBA 10/2019 - 11/2015
2	Rilpivirine (TMC-278)IBA 01/2016 - 11/2013
2	abacavir (Ziagen)FDA Link 04/2014 - 10/2006
2	HIV Protease InhibitorsIBA 01/2009 - 10/2003
2	Ritonavir (Norvir)FDA Link 06/2008 - 04/2002
2	efavirenz (Sustiva)FDA Link 10/2002 - 03/2002
2	Methadone (Dolophine)FDA LinkGeneric 04/2002 - 03/2002
1	nirmatrelvir and ritonavir drug combinationIBA 12/2022
1	Oxygen (Dioxygen)IBA 12/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fluvoxamine (Luvox)FDA LinkGeneric 01/2022
1	Drug CombinationsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	grazoprevirIBA 10/2019
1	sofosbuvir drug combination ledipasvirIBA 10/2019
1	velpatasvirIBA 10/2019
1	glecaprevir and pibrentasvirIBA 10/2019
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 10/2019
1	daclatasvirIBA 10/2019
1	elbasvirIBA 10/2019
1	Telmisartan (Micardis)FDA Link 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2015
1	HLA-B57 antigenIBA 04/2014
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 03/2013
1	artenimol (dihydroartemisinin)IBA 03/2013
1	Lumefantrine FDA Link 03/2013
1	Artemether FDA Link 03/2013
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 06/2011
1	LipidsIBA 01/2010
1	fosamprenavir (Lexiva)FDA Link 01/2010
1	Organic Anion TransportersIBA 11/2009
1	Peptides (Polypeptides)IBA 01/2009
1	AnionsIBA 01/2009
1	AdipokinesIBA 07/2008
1	vasectrin I (VS I)IBA 06/2008
1	Antitubercular AgentsIBA 05/2007
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2006
1	CholesterolIBA 06/2005
1	InterleukinsIBA 01/2005
1	AdiponectinIBA 01/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005
1	AcidsIBA 02/2004
1	Glycoproteins (Glycoprotein)IBA 02/2004
1	Glucose (Dextrose)FDA LinkGeneric 10/2003
1	Opioid Analgesics (Opioids)IBA 04/2002
1	Opiate AlkaloidsIBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2007
2	Highly Active Antiretroviral Therapy (HAART) 08/2013 - 02/2011
1	Liver Transplantation 10/2019
1	Ambulatory Care (Outpatient Care) 01/2016
1	Injections 01/2016